Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Saint Helena › NPI 1720078082
Hospital

ST. Helena Hospital

ST. Helena Hospital was paid $6.20M by Medicaid between Jan 2018 and Nov 2024, across 110 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoST. HELENA HOSPITAL
SAINT HELENA, CA 94574
33aNPI1720078082assigned 10/26/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.20M
24GClaims124,352
24DCodes billed110
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#212 of 410
Median peer was paid$6.90M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201815,928$836K
201916,242$747K
202011,913$466K
202121,335$964K
202221,028$1.12M
202321,648$1.25M
2024incomplete16,258$818K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 15,750 14,000 $1.45M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 18% 5,111 3,711 $1.11M
99281 Emergency department visit for the evaluation and management, self-limited or minor 10.0% 5,742 5,199 $619K
99201 6.7% 2,304 1,755 $418K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.6% 4,745 1,314 $222K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.4% 1,482 772 $213K
J3490 Unclassified drugs 2.2% 6,543 3,162 $137K
96375 Therapeutic injection; each additional sequential IV push 2.0% 1,631 1,178 $125K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.8% 2,223 2,149 $114K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 2,353 2,206 $112K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.7% 971 948 $106K
99070 1.7% 2,696 2,093 $103K
98 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.6% 976 $99K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.3% 2,240 $83K
97139 1.2% 1,838 $73K
J2704 Injection, propofol, 10 mg 1.1% 3,495 $71K
99215 Doctor's office visit, returning patient (complex) 1.1% 1,555 $68K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,468 $61K
99214 Doctor's office visit, returning patient (more involved) <1% 2,183 $59K
97750 <1% 490 $52K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 572 $50K
80053 Comprehensive metabolic panel <1% 4,856 $47K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 732 $46K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 6,219 $44K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 964 $40K
96361 Intravenous infusion, hydration; each additional hour <1% 922 $38K
71045 Radiologic examination, chest; single view <1% 2,990 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,841 $31K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 690 $28K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 985 $28K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,520 $27K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 199 $26K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,756 $26K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 70 $23K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 52 $23K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 550 $22K
99213 Doctor's office visit, returning patient (routine) <1% 1,063 $21K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 338 $21K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 286 $20K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,748 $18K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 278 $17K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,161 $16K
71046 Radiologic examination, chest; 2 views <1% 530 $16K
88142 <1% 3,042 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,157 $15K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 218 $15K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 612 $14K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 30 $14K
80048 Basic metabolic panel (calcium, ionized) <1% 1,697 $13K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,584 $12K
J1170 Injection, hydromorphone, up to 4 mg <1% 623 $8K
81025 <1% 1,584 $8K
J0690 Injection, cefazolin sodium, 500 mg <1% 612 $8K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 52 $8K
93971 <1% 42 $7K
81001 <1% 1,415 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 211 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 79 $6K
77067 Screening mammography, bilateral, including computer-aided detection <1% 40 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 56 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 926 $6K
96367 <1% 34 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 156 $5K
J7050 Infusion, normal saline solution, 250 cc <1% 515 $3K
88304 <1% 298 $3K
78815 Positron emission tomography (PET) for limited area imaging <1% 14 $3K
83690 <1% 538 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 387 $3K
84484 <1% 339 $3K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 116 $3K
92522 <1% 13 $3K
85610 <1% 713 $3K
97010 <1% 56 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 59 $2K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 98 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 313 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 316 $2K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 41 $2K
83605 <1% 184 $2K
82948 <1% 378 $1K
81003 <1% 603 $1K
99152 <1% 45 $1K
87400 <1% 50 $1K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 39 $910.12
99205 Prolong outpt/office vis <1% 13 $820.40
73502 <1% 13 $807.04
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 13 $797.03
82962 <1% 267 $721.68
87581 <1% 29 $716.03
87486 <1% 29 $716.03
84443 Thyroid stimulating hormone (TSH) <1% 52 $635.86
45381 <1% 12 $580.89
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 30 $560.06
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 17 $557.62
59025 Fetal non-stress test <1% 17 $550.29
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 52 $500.55
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 43 $390.37
85730 <1% 80 $359.53
88307 <1% 12 $331.96
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 15 $260.64
J2270 Injection, morphine sulfate, up to 10 mg <1% 28 $254.57
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 25 $239.07
88300 <1% 48 $167.09
87040 <1% 13 $163.88
83615 <1% 31 $145.77
80061 Lipid panel <1% 16 $138.45
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 24 $121.82
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 12 $80.40
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 44 $4.92
99349 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHERBER, STEVEN (CEO)